DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 134 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $739,518 | -49.1% | 65,852 | -43.8% | 0.01% | -50.0% |
| Q1 2024 | $1,453,397 | -10.6% | 117,115 | +0.7% | 0.01% | -16.7% |
| Q4 2023 | $1,626,335 | +87.5% | 116,333 | +98.1% | 0.01% | +71.4% |
| Q3 2023 | $867,413 | +29.4% | 58,728 | +13.2% | 0.01% | +40.0% |
| Q2 2023 | $670,483 | +337.3% | 51,895 | +232.0% | 0.01% | +400.0% |
| Q1 2023 | $153,340 | -45.7% | 15,631 | -41.1% | 0.00% | -50.0% |
| Q4 2022 | $282,513 | +5.0% | 26,552 | +2.9% | 0.00% | 0.0% |
| Q3 2022 | $269,000 | -61.1% | 25,800 | -53.1% | 0.00% | -60.0% |
| Q2 2022 | $692,000 | -59.8% | 54,989 | -60.4% | 0.01% | -54.5% |
| Q3 2018 | $1,720,000 | -5.4% | 138,719 | +16.2% | 0.01% | -8.3% |
| Q2 2018 | $1,819,000 | -18.4% | 119,336 | +6.3% | 0.01% | +140.0% |
| Q1 2018 | $2,228,000 | +13.8% | 112,278 | +7.2% | 0.01% | 0.0% |
| Q4 2017 | $1,958,000 | -16.5% | 104,756 | -3.9% | 0.01% | -16.7% |
| Q3 2017 | $2,345,000 | – | 109,039 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 8,452,235 | $30,259,000 | 7.79% |
| Senvest Management, LLC | 4,874,129 | $17,449,000 | 1.50% |
| Bain Capital Public Equity Management II, LLC | 3,345,346 | $11,960,000 | 1.14% |
| Chicago Capital, LLC | 4,380,216 | $15,659,000 | 1.05% |
| Rhenman & Partners Asset Management AB | 1,234,335 | $4,413,000 | 0.55% |
| Sio Capital Management, LLC | 465,299 | $1,663,000 | 0.54% |
| RA Capital Management | 2,365,912 | $8,458,000 | 0.50% |
| Maven Securities LTD | 264,989 | $931,000 | 0.29% |
| Rock Springs Capital Management LP | 1,850,000 | $6,614,000 | 0.26% |
| GABLES CAPITAL MANAGEMENT INC. | 64,050 | $231,000 | 0.16% |